Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-167242
Filing Date
2020-06-12
Accepted
2020-06-12 09:16:32
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d942797d424b5.htm 424B5 157046
2 GRAPHIC g942797g63p02.jpg GRAPHIC 33742
  Complete submission text file 0001193125-20-167242.txt   204764
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 424B5 | Act: 33 | File No.: 333-238056 | Film No.: 20959052
SIC: 2834 Pharmaceutical Preparations